MICHELE EGOLF: Open Payments
NPI 1205442316 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$491 in 13 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $109 · 2025 $491
Food & beverage: $391Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $139 |
| Medtronic, Inc. | 2 | $97 |
| Boston Scientific Corporation | 1 | $86 |
| Sumitomo Pharma America, Inc. | 2 | $56 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| ABBVIE INC. | 1 | $30 |
| Endo USA, Inc. | 1 | $23 |
| PFIZER INC. | 1 | $21 |
Products named: ERLEADA, INTERSTIM, Axonics, GEMTESA, Nubeqa, LUPRON DEPOT, XIAFLEX, PADCEV.
Industry payments across PA — which companies pay providers there.
